We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+8.98%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$870M
AUM Growth
+$47.6M
Cap. Flow
+$28.3M
Cap. Flow %
3.25%
Top 10 Hldgs %
41.99%
Holding
97
New
35
Increased
13
Reduced
14
Closed
20

Top Buys

Rank Stock Value
1
RNR icon
RenaissanceRe
RNR
+$27.4M
2
PANW icon
Palo Alto Networks
PANW
+$20.2M
3
ACGL icon
Arch Capital
ACGL
+$17M
4
URI icon
United Rentals
URI
+$16.1M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$15M

Top Sells

Rank Stock Value
1
LAD icon
Lithia Motors
LAD
+$24.9M
2
FOUR icon
Shift4
FOUR
+$18M
3
BFH icon
Bread Financial
BFH
+$13.1M
4
PAGS icon
PagSeguro Digital
PAGS
+$12.6M
5
GNRC icon
Generac Holdings
GNRC
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.24%
2 Financials 12.16%
3 Industrials 8.68%
4 Consumer Discretionary 7.96%
5 Communication Services 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JSPR icon
51
Jasper Therapeutics
JSPR
$23.6M
$4.24M 0.49%
+54,000
New +$5.05M
BBBY
52
CALL
Bed Bath & Beyond
BBBY
$442M
$4.13M 0.48%
+77,000
New +$5.82M
IMGO
53
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$4.12M 0.47%
173,830
– –
MTEM
54
DELISTED
Molecular Templates, Inc.
MTEM
$4M 0.46%
68,088
– –
VINC
55
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$3.92M 0.45%
19,250
+4,005
+26% +$999K
RAPT
56
CALL
DELISTED
RAPT Therapeutics
RAPT
$3.67M 0.42%
+12,500
New +$3.34M
NUVB icon
57
Nuvation Bio
NUVB
$2.32B
$3.6M 0.41%
+423,500
New +$3.89M
ANIP icon
58
ANI Pharmaceuticals
ANIP
$1.78B
$3M 0.34%
+65,000
New +$2.79M
MSAC
59
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$2.92M 0.34%
300,000
– –
TMQ
60
Trilogy Metals
TMQ
$656M
$2.76M 0.32%
1,673,461
– –
GEG icon
61
Great Elm Group
GEG
$69.3M
$2.63M 0.3%
1,259,049
– –
WNS
62
DELISTED
WNS Holdings
WNS
$2.43M 0.28%
27,500
-12,500
-31% -$1.07M
XAIR icon
63
CALL
Beyond Air
XAIR
$3.86M
$2.36M 0.27%
+625
New +$2.79M
GNCA
64
DELISTED
Genocea Biosciences, Inc.
GNCA
$2.29M 0.26%
1,972,056
– –
RDUS
65
DELISTED
Radius Health, Inc.
RDUS
$2.25M 0.26%
+325,000
New +$4.77M
RXDX
66
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$2.03M 0.23%
+51,332
New +$1.61M
EUCR
67
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$1.95M 0.22%
200,000
– –
BBIO icon
68
CALL
BridgeBio Pharma
BBIO
$16.5B
$1.67M 0.19%
+100,000
New +$4.23M
IFRX icon
69
InflaRx
IFRX
$271M
$1.55M 0.18%
325,000
-75,000
-19% -$302K
DCPH
70
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.47M 0.17%
+150,000
New +$2.82M
NVNO
71
enVVeno Medical
NVNO
$7.09M
$1.44M 0.17%
+6,262
New +$1.76M
FHTX icon
72
Foghorn Therapeutics
FHTX
$360M
$1.24M 0.14%
54,341
-151,400
-74% -$2.18M
RDUS
73
CALL
DELISTED
Radius Health, Inc.
RDUS
$1.08M 0.12%
+156,800
New +$2.3M
NEXI
74
DELISTED
NexImmune, Inc. Common Stock
NEXI
$544K 0.06%
4,718
– –
BKKT icon
75
CALL
Bakkt Inc
BKKT
$337M
$255K 0.03%
+1,200
New +$496K
1 2
3
4

Similar funds

GC
Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return
ICP
Ironvine Capital Partners Omaha, Nebraska $910M AUM 10.64% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $913M AUM 25.32% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
SI
Symmetry Investments St Helier, Jersey $913M AUM 30.59% 1-Year Est. Return
PAMI
Perseverance Asset Management International George Town, Cayman Islands $909M AUM 17.42% 1-Year Est. Return
BDP
Brehaut David Pascal $908M AUM
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Kingdon Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Kingdon Capital Management held 97 positions worth $870M, up 5.8% from $822M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Kingdon Capital Management deployed $28.3M of net new capital in Q4 2021, opening 35 new positions and adding to 13 existing holdings. Its largest new stake was RenaissanceRe: 175,000 shares worth $29.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Walt Disney, an estimated $11M trimmed.

  • Kingdon Capital Management's largest Q4 2021 buy was RenaissanceRe: 175,000 shares worth $29.6M.
  • Kingdon Capital Management added most to Humana in Q4 2021, an estimated $10.3M increase.
  • Kingdon Capital Management's biggest Q4 2021 reduction was Walt Disney, cutting an estimated $11M.
  • Kingdon Capital Management fully exited Lithia Motors in Q4 2021, selling an estimated $24.9M.
  • Kingdon Capital Management's ten largest holdings make up 42% of its $870M portfolio in Q4 2021.
  • Kingdon Capital Management opened 35 new positions and closed 20 in Q4 2021.
  • Kingdon Capital Management's portfolio value rose 5.8% quarter-over-quarter to $870M.

Based on Kingdon Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.